Skip to main content
Notice2026-18924

L-lysine From the People's Republic of China: Antidumping Duty Order and Countervailing Duty Order

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
September 16, 2026

Issuing agencies

Commerce DepartmentInternational Trade Administration

Abstract

Based on affirmative final determinations by the U.S. Department of Commerce (Commerce) and the U.S. International Trade Commission (ITC), Commerce is issuing antidumping duty (AD) and countervailing duty (CVD) orders on L-lysine (lysine) from the People's Republic of China (China).

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 178 (Wednesday, September 16, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 178 (Wednesday, September 16, 2026)]
[Notices]
[Pages 58627-58631]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-18924]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

International Trade Administration

[A-570-215, C-570-216]


L-lysine From the People's Republic of China: Antidumping Duty 
Order and Countervailing Duty Order

AGENCY: Enforcement and Compliance, International Trade Administration, 
Department of Commerce.

SUMMARY: Based on affirmative final determinations by the U.S. 
Department of Commerce (Commerce) and the U.S. International Trade 
Commission (ITC), Commerce is issuing antidumping duty (AD) and 
countervailing duty (CVD) orders on L-lysine (lysine) from the People's 
Republic of China (China).

DATES: Applicable September 16, 2026.

FOR FURTHER INFORMATION CONTACT: Jerry Xiao (AD) at (202) 482-2273; or 
Grant Fuller (CVD) at (202) 482-6228, AD/CVD Operations, Offices II and 
IX, Enforcement and Compliance, International Trade Administration, 
U.S. Department of Commerce, 1401 Constitution Avenue NW, Washington, 
DC 20230.

SUPPLEMENTARY INFORMATION:

Background

    In accordance with sections 705(d) and 735(d) of the Tariff Act of 
1930, as amended (the Act), on July 23, 2026, Commerce published its 
affirmative final determination of sales at less than fair value (LTFV) 
of lysine from China and its affirmative final determination that 
countervailable subsidies are being provided to producers and exporters 
of lysine from China.\1\
---------------------------------------------------------------------------

    \1\ See L-Lysine from the People's Republic of China: Final 
Affirmative Determination of Sales at Less Than Fair Value, 91 FR 
46406 (July 23, 2026) (AD Final Determination); see also L-Lysine 
from the People's Republic of China: Final Affirmative 
Countervailing Duty Determination, 91 FR 46399 (July 23, 2026) (CVD 
Final Determination).
---------------------------------------------------------------------------

    On September 2, 2026, pursuant to sections 705(d) and 735(d) of the 
Act, the ITC notified Commerce of its final affirmative determinations 
that an industry in the United States is materially injured by reason 
of dumped imports of lysine from China, and subsidized imports of 
lysine from China, within the meaning of sections

[[Page 58628]]

705(b)(1)(A)(i) and 735(b)(1)(A)(i) of the Act.\2\ On September 8, 
2026, the ITC published its final determinations in the Federal 
Register.\3\
---------------------------------------------------------------------------

    \2\ See ITC's Letter, ``Chairman Transmittal of Determination,'' 
dated September 2, 2026 (ITC Notification Letter).
    \3\ See L-lysine from China, 91 FR 57162 (September 8, 2026) 
(ITC Final Determination).
---------------------------------------------------------------------------

Scope of the Orders

    The products covered by these orders are lysine from China. For a 
complete description of the scope of the orders, see the appendix to 
this notice.

AD Order

    On September 2, 2026, in accordance with section 735(d) of the Act, 
the ITC notified Commerce of its final determination that an industry 
in the United States is materially injured within the meaning of 
section 735(b)(1)(A)(i) of the Act by reason of imports of lysine from 
China that are sold in the United States at LTFV.\4\ Therefore, in 
accordance with sections 735(c)(2) and 736 of the Act, Commerce is 
issuing this AD order. Because the ITC determined that an industry in 
the United States is materially injured by reason of imports of lysine 
from China, unliquidated entries of such merchandise from the 
countries, entered or withdrawn from warehouse for consumption, are 
subject to the assessment of antidumping duties.
---------------------------------------------------------------------------

    \4\ See ITC Notification Letter.
---------------------------------------------------------------------------

    Therefore, in accordance with section 736(a)(1) of the Act, 
Commerce will direct U.S. Customs and Border Protection (CBP) to 
assess, upon further instruction by Commerce, antidumping duties equal 
to the amount by which the normal value of the merchandise exceeds the 
export price (or constructed export price) of the merchandise on all 
relevant entries of lysine from China. Antidumping duties will be 
assessed on unliquidated entries of lysine entered, or withdrawn from 
warehouse, for consumption on or after March 6, 2026, the date of 
publication of the AD Preliminary Determination,\5\ but will not 
include entries occurring after the expiration of the provisional 
measures period and before publication of the ITC's final injury 
determination, as further described in the ``Provisional Measures--AD'' 
section of this notice.
---------------------------------------------------------------------------

    \5\ See L-Lysine from the People's Republic of China: 
Preliminary Affirmative Determination of Sales at Less Than Fair 
Value, Postponement of Final Determination, and Extension of 
Provisional Measures, 91 FR 11030 (March 6, 2026) (AD Preliminary 
Determination).
---------------------------------------------------------------------------

Suspension of Liquidation and Cash Deposits--AD

    In accordance with section 736 of the Act, Commerce intends to 
instruct CBP to reinstitute the suspension of liquidation and continue 
the suspension of liquidation, as applicable, on all relevant entries 
of lysine from China, effective on September 8, 2026, the date of 
publication of the ITC's final affirmative injury determination in the 
Federal Register.\6\
---------------------------------------------------------------------------

    \6\ See ITC Final Determination.
---------------------------------------------------------------------------

    Commerce also intends to instruct CBP to require cash deposits 
equal to the estimated weighted-average dumping margins indicated in 
the tables below, adjusted by the relevant subsidy offsets. 
Accordingly, effective on the date of publication in the Federal 
Register of the notice of the ITC's final affirmative injury 
determination, CBP will require, at the same time as importers would 
normally deposit estimated customs duties on subject merchandise, a 
cash deposit equal to the rates listed in the tables below. The rate 
for the China-wide entity applies to all producers or exporter 
combinations not specifically listed, as appropriate. These 
instructions suspending liquidation and cash deposit requirements will 
remain in effect until further notice.

Estimated Weighted-Average Dumping Margins

    The estimated weighted-average dumping margins are as follows:

----------------------------------------------------------------------------------------------------------------
                                                                                               Cash deposit rate
                                                                             Weighted-average    (Adjusted for
                  Producer                              Exporter              dumping margin    subsidy offsets)
                                                                                (percent)          (percent)
----------------------------------------------------------------------------------------------------------------
Anhui BBCA Biochemical Co., Ltd............  Zhengzhou Longgu Trading Co.,           * 139.83             139.65
                                              Ltd.
Eppen Asia Pte. Ltd./Heilongjiang Eppen      Zhengzhou Longgu Trading Co.,           * 139.83             139.65
 Biotech Co., Ltd./Inner Mongolia Eppen       Ltd.
 Biotech Co., Ltd./Ningxia Eppen Biotech
 Co., Ltd.
Shouguang Golden Corn Biotechnological Co.,  Zhengzhou Longgu Trading Co.,           * 139.83             139.65
 Ltd.                                         Ltd.
Shouguang Golden Corn Biotechnological Co.,  Zhengzhou Heshu Stockbreeding           * 139.83             139.65
 Ltd.                                         Development Co., Ltd.
Eppen Asia Pte. Ltd./Heilongjiang Eppen      Zhengzhou Heshu Stockbreeding           * 139.83             139.65
 Biotech Co., Ltd./Inner Mongolia Eppen       Development Co., Ltd.
 Biotech Co., Ltd./Ningxia Eppen Biotech
 Co., Ltd.
Anhui BBCA Biochemical Co., Ltd............  Agromate Sg Pte. Ltd.........              73.55              73.37
Heilongjiang Wanlirunda Biotechnology Co.,   Agromate Sg Pte. Ltd.........              73.55              73.37
 Ltd.
Eppen Asia Pte. Ltd./Heilongjiang Eppen      Agromate Sg Pte. Ltd.........              73.55              73.37
 Biotech Co., Ltd./Inner Mongolia Eppen
 Biotech Co., Ltd./Ningxia Eppen Biotech
 Co., Ltd.
Shouguang Golden Corn Biotechnological Co.,  Ainore (Tianjin) Trading Co.,              73.55              73.37
 Ltd.                                         Ltd.
Heilongjiang Wanlirunda Biotechnology Co.,   Ainore (Tianjin) Trading Co.,              73.55              73.37
 Ltd.                                         Ltd.
Anhui BBCA Biochemical Co., Ltd............  Aollen Biotech Co., Ltd......              73.55              73.37
Changchun Dahe Bio Technology Development    Aollen Biotech Co., Ltd......              73.55              73.37
 Co., Ltd.
Eppen Asia Pte. Ltd./Heilongjiang Eppen      Aollen Biotech Co., Ltd......              73.55              73.37
 Biotech Co., Ltd./Inner Mongolia Eppen
 Biotech Co., Ltd./Ningxia Eppen Biotech
 Co., Ltd.
Heilongjiang Wanlirunda Biotechnology Co.,   Aollen Biotech Co., Ltd......              73.55              73.37
 Ltd.
Henan Jinyufeng Biotechnology Co., Ltd.....  Aollen Biotech Co., Ltd......              73.55              73.37
Jilin Meihua Amino Acid Co., Ltd...........  Aollen Biotech Co., Ltd......              73.55              73.37
Qiqihar Longjiang Fufeng Biotechnologies     Aollen Biotech Co., Ltd......              73.55              73.37
 Co., Ltd.
Shouguang Golden Corn Biotechnological Co.,  Aollen Biotech Co., Ltd......              73.55              73.37
 Ltd.

[[Page 58629]]

 
Zhucheng Dongxiao Biotechnology Co., Ltd...  Aollen Biotech Co., Ltd......              73.55              73.37
Eppen Asia Pte. Ltd./Heilongjiang Eppen      Pegasus Ltd..................              73.55              73.37
 Biotech Co., Ltd./Inner Mongolia Eppen
 Biotech Co., Ltd./Ningxia Eppen Biotech
 Co., Ltd.
Shandong Shouguang Juneng Golden Corn        Pegasus Ltd..................              73.55              73.37
 Development Co., Ltd.
Qiqihar Longjiang Fufeng Biotechnologies     Pegasus Ltd..................              73.55              73.37
 Co., Ltd.
Qiqihar Longjiang Fufeng Biotechnologies     Qiqihar Longjiang Fufeng                   73.55              73.37
 Co., Ltd.                                    Biotechnologies Co., Ltd.
Shouguang Golden Corn Biotechnological Co.,  Shouguang Golden Corn                      73.55              73.37
 Ltd.                                         Biotechnological Co., Ltd.
    China-wide Entity......................                                          * 139.83             139.65
----------------------------------------------------------------------------------------------------------------
* Rate based on facts available with adverse inferences.

Provisional Measures--AD
    Section 773(d) of the Act states that suspension of liquidation 
pursuant to an affirmative preliminary determination may not remain in 
effect for more than four months, except where exporters representing a 
significant proportion of exports of the subject merchandise request 
that Commerce extend the four-month period to no more than six months. 
At the request of exporters that account for a significant proportion 
of lysine from China, Commerce extended the four-month period to six 
months.\7\
---------------------------------------------------------------------------

    \7\ See AD Preliminary Determination, 91 FR at 11033.
---------------------------------------------------------------------------

    In the underlying investigation, Commerce published the Preliminary 
Determinations on March 6, 2026. Therefore, the six-month period 
beginning on the date of the publication of the Preliminary 
Determinations ended on September 1, 2026. In accordance with section 
733(d) of the Act and our practice, Commerce will instruct CBP to 
terminate the suspension of liquidation and to liquidate, without 
regard to antidumping duties, unliquidated entries of lysine from China 
entered, or withdrawn from warehouse, for consumption on or after 
September 2, 2026, the day on which the provisional AD measures 
expired, until and through the day preceding the date of publication of 
the ITC's final injury determination in the Federal Register.\8\ 
Suspension of liquidation and the collection of cash deposits will 
resume on the date of publication of the ITC's final determinations in 
the Federal Register.
---------------------------------------------------------------------------

    \8\ See ITC Final Determination.
---------------------------------------------------------------------------

CVD Order

    As stated above, on September 2, 2026, the ITC notified Commerce of 
its final determination that an industry is materially injured within 
the meaning of section 705(b)(1)(A)(i) of the Act by reason of 
subsidized imports of lysine from China.\9\ Therefore, in accordance 
with sections 705(c)(2) and 706 of the Act, Commerce is issuing this 
CVD order. Because the ITC determined that an industry in the United 
States is materially injured by reason of subsidized imports of lysine 
from China, unliquidated entries of such merchandise from the 
countries, entered or withdrawn from warehouse for consumption, are 
subject to the assessment of countervailing duties.
---------------------------------------------------------------------------

    \9\ See ITC Notification Letter.
---------------------------------------------------------------------------

    Therefore, in accordance with section 706(a) of the Act, Commerce 
will direct CBP to assess, upon further instruction by Commerce, 
countervailing duties on all relevant entries of lysine from China, 
which are entered, or withdrawn from warehouse, for consumption on or 
after January 22, 2026, the date of publication of the CVD Preliminary 
Determination,\10\ but will not include entries occurring after the 
expiration of the provisional measures period and before publication of 
the ITC's final injury determination, as further described in the 
``Provisional Measures--CVD'' section of this notice.
---------------------------------------------------------------------------

    \10\ See L-Lysine from the People's Republic of China: 
Preliminary Affirmative Countervailing Duty Determination and 
Alignment of Final Determination With Final Antidumping Duty 
Determination, 91 FR 2745 (January 22, 2026) (CVD Preliminary 
Determination).
---------------------------------------------------------------------------

Suspension of Liquidation and Cash Deposits--CVD

    In accordance with section 706 of the Act, Commerce intends to 
instruct CBP to reinstitute the suspension of liquidation and continue 
the suspension of liquidation, as applicable, on all relevant entries 
of lysine from China, effective on September 9, 2026, the date of 
publication of the ITC's final affirmative injury determination in the 
Federal Register,\11\ and to assess, upon further instruction by 
Commerce, countervailing duties on each entry of subject merchandise in 
an amount based on the net countervailable subsidy rates below.
---------------------------------------------------------------------------

    \11\ See ITC Final Determination.
---------------------------------------------------------------------------

    Commerce also intends to instruct CBP to require cash deposits 
equal to the amounts indicated in the tables below. Accordingly, 
effective on the date of publication in the Federal Register of the 
notice of the ITC's final affirmative injury determination, CBP will 
require, at the same time as importers would normally deposit estimated 
customs duties on subject merchandise, a cash deposit equal to the 
rates listed in the tables below. The all-others rate applies to all 
producers or exporters not specifically listed, as appropriate.
    These instructions suspending liquidation and cash deposit 
requirements will remain in effect until further notice.

Estimated CVD Subsidy Rates

    The estimated CVD subsidy rates, as published in Commerce's CVD 
Final Determination, are as follows:

------------------------------------------------------------------------
                                                  Subsidy rate  (percent
               Exporter/producer                       ad valorem)
------------------------------------------------------------------------
Inner Mongolia Eppen Biotech Co. Ltd.\12\......                    48.21
Helionjiang Wanli Runda Biotechnology Co., Ltd.                  * 82.11

[[Page 58630]]

 
Shouguang Golden-land Industry & Trading Co.,                    * 82.11
 Ltd...........................................
All Others.....................................                    48.21
------------------------------------------------------------------------
* Rate based on facts available with adverse inferences.

Provisional Measures--CVD
---------------------------------------------------------------------------

    \12\ Commerce has found the following companies to be cross-
owned with Inner Mongolia Eppen: Heilongjiang Eppen Trading Co., 
Ltd.; Heilongjiang Eppen Biotech Co., Ltd.; Heilongjiang Eppen 
Energy Co.; Ningxia Eppen Biotech Co. Ltd.; Star Lake Bioscience 
Co., Ltd Zhaoqing Guangdong; and Guangdong Guangxin Holdings Group 
Ltd.
---------------------------------------------------------------------------

    Section 703(d) of the Act states that suspension of liquidation 
pursuant to an affirmative preliminary determination may not remain in 
effect for more than four months. Commerce published the CVD 
Preliminary Determination on January 22, 2026. Therefore, the four-
month period beginning on the date of the publication of the CVD 
Preliminary Determination ended on May 21, 2026.
    Therefore, in accordance with section 703(d) of the Act and our 
practice, Commerce will instruct CBP to terminate the suspension of 
liquidation and to liquidate, without regard to countervailing duties, 
unliquidated entries of lysine from China entered, or withdrawn from 
warehouse, for consumption on or after May 22, 2026, the first day 
provisional measures were no longer in effect, until and through the 
day preceding the date of publication of the ITC's final injury 
determinations in the Federal Register. Suspension of liquidation and 
the collection of cash deposits will resume on the date of publication 
of the ITC's final determinations in the Federal Register.

Establishment of the Annual Inquiry Service Lists

    On September 20, 2021, Commerce published the Final Rule in the 
Federal Register.\13\ On September 27, 2021, Commerce also published 
the Procedural Guidance in the Federal Register.\14\ The Final Rule and 
Procedural Guidance provide that Commerce will maintain an annual 
inquiry service list for each order or suspended investigation, and any 
interested party submitting a scope ruling application or request for 
circumvention inquiry shall serve a copy of the application or request 
on the persons on the annual inquiry service list for that order, as 
well as any companion order covering the same merchandise from the same 
country of origin.
---------------------------------------------------------------------------

    \13\ See Regulations to Improve Administration and Enforcement 
of Antidumping and Countervailing Duty Laws, 86 FR 52300 (September 
20, 2021) (Final Rule).
    \14\ See Scope Ruling Application; Annual Inquiry Service List; 
and Informational Sessions, 86 FR 53205 (September 27, 2021) 
(Procedural Guidance).
---------------------------------------------------------------------------

    In accordance with the Procedural Guidance, for orders published in 
the Federal Register after November 21, 2021, Commerce will create an 
annual inquiry service list segment in Commerce's online e-filing and 
document management system, Antidumping and Countervailing Duty 
Electronic Service System (ACCESS), available at <a href="https://access.trade.gov">https://access.trade.gov</a>, within five business days of publication of the 
notice of the order. Each annual inquiry service list will be saved in 
ACCESS, under each case number, and under a specific segment type 
called ``AISL-Annual Inquiry Service List.'' \15\
---------------------------------------------------------------------------

    \15\ This segment will be combined with the ACCESS Segment 
Specific Information (SSI) field which will display the month in 
which the notice of the order or suspended investigation was 
published in the Federal Register, also known as the anniversary 
month. For example, for an order under case number A-000-000 that 
was published in the Federal Register in January, the relevant 
segment and SSI combination will appear in ACCESS as ``AISL-January 
Anniversary.'' Note that there will be only one annual inquiry 
service list segment per case number, and the anniversary month will 
be pre-populated in ACCESS.
---------------------------------------------------------------------------

    Interested parties who wish to be added to the annual inquiry 
service list for an order must submit an entry of appearance to the 
annual inquiry service list segment for the order in ACCESS within 30 
days after the date of publication of the order. For ease of 
administration, Commerce requests that law firms with more than one 
attorney representing interested parties in an order designate a lead 
attorney to be included on the annual inquiry service list. Commerce 
will finalize the annual inquiry service list within five business days 
thereafter. As mentioned in the Procedural Guidance, \16\ the new 
annual inquiry service list will be in place until the following year, 
when the Opportunity Notice for the anniversary month of the order is 
published.
---------------------------------------------------------------------------

    \16\ See Procedural Guidance, 86 FR at 53206.
---------------------------------------------------------------------------

    Commerce may update an annual inquiry service list at any time as 
needed based on interested parties' amendments to their entries of 
appearance to remove or otherwise modify their list of members and 
representatives, or to update contact information. Any changes or 
announcements pertaining to these procedures will be posted to the 
ACCESS website.

Special Instructions for the Petitioner and Foreign Governments

    In the Final Rule, Commerce stated that, ``after an initial request 
and placement on the annual inquiry service list, both petitioners and 
foreign governments will automatically be placed on the annual inquiry 
service list in the years that follow.'' \17\ Accordingly, as stated 
above, the petitioner and foreign governments should submit their 
initial entries of appearance after publication of this notice in order 
to appear in the first annual inquiry service lists for these orders. 
Pursuant to 19 CFR 351.225(n)(3), the petitioner and foreign 
governments will not need to resubmit their entries of appearance each 
year to continue to be included on the annual inquiry service list. 
However, the petitioner and foreign governments are responsible for 
making amendments to their entries of appearance during the annual 
update to the annual inquiry service list in accordance with the 
procedures described above.
---------------------------------------------------------------------------

    \17\ See Final Rule, 86 FR at 52335.
---------------------------------------------------------------------------

Notification to Interested Parties

    This notice constitutes the AD and CVD orders with respect to 
lysine from China, pursuant to section 736(a) of the Act. Interested 
parties can find a list of AD and CVD orders currently in effect at 
<a href="https://www.trade.gov/data-visualization/adcvd-proceedings">https://www.trade.gov/data-visualization/adcvd-proceedings</a>.
    These orders are published in accordance with sections 706(a) and 
736(a) of the Act, and 19 CFR 351.211(b).

     Dated: September 11, 2026.
Christopher Abbott,
Deputy Assistant Secretary for Policy and Negotiations, performing the 
non-exclusive functions and duties of the Assistant Secretary for 
Enforcement and Compliance.

Appendix

Scope of the Orders

    The scope of these orders covers animal feed grade L-lysine 
(lysine). Lysine is an essential amino acid added to animal feed 
that is used in the biosynthesis of proteins. The scope covers 
lysine regardless of form, including lysine monohydrochloride, also

[[Page 58631]]

referred to as lysine HCL, lysine sulfate, and liquid lysine. The 
scope includes lysine that has been coated or encapsulated for use 
with ruminants to ensure bioavailability.
    Lysine HCL in the dry form has the molecular formula 
C6H14N2O2HCl. The Chemical Abstracts Service (CAS) registry number 
for lysine HCL is 657-27-2. Lysine HCL contains a minimum of 78 
percent lysine by weight, as well as additional amino acids, 
carbohydrates, mineral salts, and organic acids. Lysine sulfate is 
the sulfate salt of lysine, and in the dry form it has the molecular 
formula C6H16N2O6S. The CAS registry number for lysine sulfate is 
60343-69-3. Lysine sulfate typically contains approximately 40-70 
percent lysine by weight, as well as additional amino acids, 
carbohydrates, mineral salts, and organic acids. Liquid lysine is a 
concentrated form of lysine in an aqueous solution with the 
molecular formula C6H14N2O2. The CAS registry number for liquid 
lysine is 56-87-1. Liquid lysine normally contains at least 50 
percent lysine by weight, as well as additional amino acids, 
carbohydrates, mineral salts, and organic acids.
    The scope includes animal feed grade lysine that is combined 
with other products, including for example, by mixing, blending, 
compounding, or granulating (e.g., base mixes, premixes, and 
concentrates). For such combined products, only the lysine component 
is covered by the scope of these orders.
    Subject merchandise also includes lysine that has been processed 
in a third country, including by commingling, diluting, adding or 
removing additives, refining, converting from liquid to dry or dry 
to liquid form, coating or encapsulating, or performing any 
processing that would not otherwise remove the merchandise from the 
scope of these orders if performed in the subject country.
    The merchandise covered by these orders is properly classified 
under Harmonized Tariff Schedule of the United States (HTSUS) 
subheading 2922.41.0090. Lysine may also be classified under HTSUS 
subheadings 2922.41.0010, 2922.49.4950, 2309.90.7000, and 
2309.90.9500. Although the HTSUS subheadings and the CAS registry 
numbers are provided for convenience and customs purposes, the 
written description of the scope of these orders is dispositive.

[FR Doc. 2026-18924 Filed 9-15-26; 8:45 am]
BILLING CODE 3510-DS-P


</pre></body>
</html>
Indexed from Federal Register on September 16, 2026.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.